cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Bristol Myers Squibb Co
170 own
95 watching
Current Price
$42.23
$0.3
(0.72%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
83,516.52M
52-Week High
52-Week High
65.38000
52-Week Low
52-Week Low
39.63000
Average Volume
Average Volume
10.75M
Dividend Yield
Dividend Yield
0.032969
P/E Ratio
P/E Ratio
16.83
iconMarket Capitalization83,516.52M
icon52-Week High65.38000
icon52-Week Low39.63000
iconAverage Volume10.75M
iconDividend Yield0.032969
iconP/E Ratio16.83
What does the Bristol Myers Squibb Co do?
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, and distributes biopharmaceutical products worldwide. The company offers chemically-synthesized drug and biologic in various therapeutic areas, such as oncology; cardiovascular; immunoscience; and virology comprising human immunodeficiency virus infection (HIV). Its products include Empliciti, a humanized monoclonal antibody to treat multiple myeloma; Opdivo, a human monoclonal antibody to treat renal cell carcinoma, non-small cell lung cancer, classical Hodgkin lymphoma, gastric cancer, melanoma, metastatic urothelial carcinoma, and squamous cell carcinoma of the head and neck; Erbitux, an IgG1 monoclonal antibody that blocks the epidermal growth factor receptor; Sprycel, a tyrosine kinase inhibitor for the treatment of adults with Philadelphia chromosome-positive chronic myeloid leukemia; and Yervoy, a monoclonal antibody for metastatic melanoma. The company's products also comprise Eliquis, an oral factor Xa inhibitor targeted at stroke prevention in atrial fibrillation; Baraclude to treat chronic hepatitis B virus; Daklinza and Sunvepra to treat hepatitis C virus (HCV); Reyataz and Sustiva to treat HIV; Abilify, an antipsychotic agent for adults with schizophrenia, bipolar mania disorder, and depressive disorder; Beclabuvir, a non-nucleoside NS5B inhibitor for the treatment of HCV; and Orencia to treat rheumatoid arthritis. It has collaborations with Portola Pharmaceuticals, Inc. to develop and commercialize andexanet alfa, an investigational agent; Apexigen, Inc. to evaluate Opdivo in combination with APX005M in patients with solid tumors; and license agreement with Nitto Denko Corporation to develop and commercialize siRNA molecules targeted at HSP47 in vitamin A. The company was formerly known as Bristol-Myers Company and changed its name to Bristol-Myers Squibb Company in 1989. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York.
Read More
How much money does Bristol Myers Squibb Co make?
News & Events about Bristol Myers Squibb Co.
Zolmax
11 months ago
Shufro Rose & Co. LLC decreased its stake in shares of Bristol-Myers Squibb (NYSE:BMY Free Report) by 13.4% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,760 shares of the biopharmaceutical...
Benzinga
12 months ago
read more...
Zolmax
12 months ago
Viking Fund Management LLC increased its holdings in shares of Bristol-Myers Squibb (NYSE:BMY Get Rating) by 82.5% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 73,000 shares of the biopharmaceutical ...
Zolmax
12 months ago
Crew Capital Management Ltd. decreased its position in Bristol-Myers Squibb (NYSE:BMY Get Rating) by 7.1% during the first quarter, HoldingsChannel.com reports. The firm owned 9,133 shares of the biopharmaceutical companys stock after selling 700 shares during the quarter. Crew Capital Management ...
Zolmax
12 months ago
Naples Global Advisors LLC increased its holdings in shares of Bristol-Myers Squibb (NYSE:BMY Get Rating) by 4.1% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 55,925 shares of the ...
Frequently Asked Questions
Frequently Asked Questions
What is Bristol Myers Squibb Co share price today?
plus_minus_icon
Can Indians buy Bristol Myers Squibb Co shares?
plus_minus_icon
How can I buy Bristol Myers Squibb Co shares from India?
plus_minus_icon
Can Fractional shares of Bristol Myers Squibb Co be purchased?
plus_minus_icon
What are the documents required to start investing in Bristol Myers Squibb Co stocks?
plus_minus_icon
What is today’s traded volume of Bristol Myers Squibb Co?
plus_minus_icon
What is today’s market capitalisation of Bristol Myers Squibb Co?
plus_minus_icon
What is the 52-Week High and Low Range of Bristol Myers Squibb Co?
plus_minus_icon
What percentage is Bristol Myers Squibb Co down from its 52-Week High?
plus_minus_icon
What percentage is Bristol Myers Squibb Co up from its 52-Week Low?
plus_minus_icon
Current Price
$42.23
$0.3
(0.72%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00